Clinical Trial Detail

NCT ID NCT02684032
Title A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements yes
Sponsors Pfizer
Indications

Her2-receptor negative breast cancer

Therapies

Letrozole

Fulvestrant

Gedatolisib + Palbociclib

Age Groups: adult

Additional content available in CKB BOOST